麻豆传媒

23% achieved HBsAg loss with xalnesiran plus immunomodulator, but relapses occurred in some

Notably, tapering reduced the risk of infection compared with a fixed dose

Also in TTHealthWatch: HIV-positive kidney donors

Fatty acid synthase inhibitor targets main drivers of liver injury

These high reinfection rates indicate treatment has reached highest-risk population

An anesthesiologist may not have followed infection control practices

Hospital setting may offer unique opportunity to increase vaccination rates

Results as quick as 1 hour, enabling a test-and-treat approach

Androgen precursor may help cirrhosis-related sarcopenia

"Is it time to say primary prophylaxis is dead?" one expert asks

GLP-1/GIP agonist also improved fibrosis biomarkers, liver fat, and stiffness in phase II trial

Effects may be related to weight loss, not changes in fibrogenesis, expert suggests

iLFT is now an essential, highly utilized tool at one U.K. primary care system

Combo therapies for HDV with drugs other than pegylated interferon would be better, expert says